Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-18-014539
Filing Date
2018-10-26
Accepted
2018-10-26 19:56:56
Documents
1
Period of Report
2018-10-24

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT ownership.html 4  
1 OWNERSHIP DOCUMENT ownership.xml 4 3483
  Complete submission text file 0001213900-18-014539.txt   5092
Mailing Address C/O AMPIO PHARMACEUTICALS, INC. 5445 DTC PARKWAY, SUITE 925 GREENWOOD VILLAGE CO 80111
Business Address
MACALUSO MICHAEL (Reporting) CIK: 0001096423 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38247 | Film No.: 181142621

Mailing Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112 (720) 437-6580
AYTU BIOSCIENCE, INC (Issuer) CIK: 0001385818 (see all company filings)

EIN.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations